Market synopsis of global keratoconus treatment market:
Market Scenario:
Keratoconus is a progressive eye disorder. In this condition, cornea thins and begins to bulge outward into a cone-like shape and causes distorted or blurred vision, increased sensitivity to bright light or glare, sudden clouding of vision etc.
Development of technologically advanced diagnostic and treatment products, growing awareness, increasing healthcare expenditure, and rising demand from emerging regions are driving the growth for global keratoconus treatment market.
Globalkeratoconus treatment market is expected to grow at the CAGR of ~4.1% during the forecast period and is estimated to reach USD 427.5 million by 2023.
Study objectives of global keratoconus treatment market:
- To provide detailed analysis of the global keratoconus treatment market structure with historical and forecast revenue for the next six years of the various segments and sub-segments.
- To provide insights about the key drivers, restraints, opportunities and challenges affecting the growth of global keratoconus treatment market
- To provide analysis of the market with respect to various countries in the four main geographies– the Americas, Europe, Asia Pacific, and Middle East & Africa.
- To provide detailed analysis of the market segmented by type, diagnosis, treatment, end user, and its sub-segments.
- To provide a detailed analysis of global keratoconus treatment market mainly based on Value Chain Analysis, Porter’s Five Forces, Price Analysis, and Supply Chain Analysis etc.
- To provide a detailed country level analysis of the market with respect to the current market size and future prospects.
- To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global keratoconus treatment market.
- To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the keratoconus treatment market.
Intended Audience:
- Keratoconus medicines manufacturers
- Keratoconus medicines and treatment providers
- Hospitals and clinics
- Medical Research laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Segments:
Global keratoconus treatment market has been segmented on the basis of type which comprises of forme fruste keratoconus, corneal hydrops, keratoglobus, pellucid marginal degeneration, posterior keratoconus, and others.
On the basis of diagnosis, the market is segmented into computerized corneal mapping, keratometry, slit-lamp examination, refraction test, and others. Slit-lamp examination includes tonometry, vision testing, and others.
On the basis of treatments, the market has been segmented into lenses, surgery, collagen cross-linking, and others. Lenses is sub-segmented into eyeglasses or soft contact lenses, hard contact lenses, piggyback lenses, hybrid lenses, scleral lenses, and others. Surgery is sub-segmented into corneal inserts, cornea transplant, and others. Collagen cross-linking is still in research process and more study is required to implement this treatment option.
On the basis of end user, it is segmented into eye hospitals & clinics, medical research centers, academic institutes, and others.
Regional analysis of global keratoconus treatment market:
Considering the global scenario of the market, America is the highest revenue generator with North American region contributing the most. North America mainly includes US and Canada. US is one of the dominant markets not only in America but also in the global market. European market is the second largest and UK is believed to be the fastest growing market for keratoconus treatment in this region. Increasing awareness, growing purchasing power, and rapidly improving healthcare sector are driving the growth for Asia Pacific keratoconus market. Asia Pacific is one of the high potential market for keratoconus treatment. Due to slow adoption of new treatments and prosucts, Middle East and Africa is expected to grow at steady pace.
Key players for global keratoconus treatment market:
Some of the key players in this market are: Bausch & Lomb Incorporated (US), CIBA VISION (US), CooperVision (US), HOYA Vision Care (Singapore), Johnson & Johnson Vision Care, Inc. (US), Menicon Co., Ltd. (Japan), Novartis AG (Switzerland), Optik Seis (Indonesia), and SAFILENS S.R.L. (Italy), and others.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/3861
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
No comments:
Post a Comment